Sort
64,565 grants matching “drug discovery”
Tools for Accelerating R&D for Historically Understudied Protein Kinases
$708,631Reena Zutshi · Luceome Biotechnologies, Llc · R44 · FY2017 · TR
Determining the pathophysiology of pediatric arteriovenous malformation
$708,558Arin K. Greene · Boston Children'S Hospital · R01 · FY2020 · HD
Multilevel Parallelization of Software for Accurate Protein-Ligand Affinities
$708,450Simon Webb · Verachem, Llc · R44 · FY2011 · GM
The development of a recombinant vaccine against human onchocerciasis
$708,326Sara Lustigman · New York Blood Center · R01 · FY2009 · AI
Developing capsid-importin alpha inhibitors for the treatment of VEEV infection
$708,202Mikell Paige · George Mason University · R01 · FY2024 · AI
Evolution of drug resistance in Candida glabrata
$708,143Gavin J Sherlock · Stanford University · R01 · FY2019 · AI
Translational Studies of the Histone Deacetylase Inhibitor Romidepsin
$708,140Susan Bates · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
UMGCC Paul Calabresi Clinical Oncology Training Program
$708,076Edward A Sausville · University Of Maryland Baltimore · K12 · FY2009 · CA
T-cell subsets as CVD risk factors in CHS and MESA
$707,950Bruce M Psaty · University Of Washington · R01 · FY2015 · HL
Examining Carbon Monoxide to Treat Inflammatory Conditions using Experimental Colitis Models
$707,948Binghe Wang · Georgia State University · R01 · FY2020 · DK
Muscarinic modulation of RDoC constructs in primate behavior and fronto-striatal circuits
$707,927Thilo Womelsdorf · Vanderbilt University · R01 · FY2024 · MH
MECHANISM-BASED DRUG SELECTION AND DESIGN: NUCLEOTIDE SA
$707,927Oregon Health And Science University · R01 · FY2001 · AI
Antibacterial inhibitors of RnpA
$707,917Paul M. Dunman · University Of Rochester · R01 · FY2018 · AI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$707,884Philip A Kern · University Of Kentucky · UL1 · FY2011 · RR
7TMR DRUG DISCOVERY, MICROFLUIDICS &HT FLOW CYTOMETRY
$707,787University Of New Mexico · R24 · FY2000 · GM
Defining the Inflammation and Immunity Transcriptome in Severe Malarial Anemia for Immunotherapeutic Discovery
$707,737Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2021 · AI
CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity
$707,707William E. Evans · St. Jude Children'S Research Hospital · P50 · FY2017 · GM
NEW ANTICANCER DRUGS FOR CULTURED AND COLLECTED MARINE O
$707,704University Of California San Diego · U19 · FY2004 · CA
MWAS+ â A Novel Drug Repurposing Strategy for ADRD Prevention
$707,646Qing Zeng · George Washington University · R01 · FY2023 · AG
Network Resource
$707,644Sook Wah Yee · University Of California, San Francisco · U19 · FY2012 · GM
Early-Stage Preclinical Validation of Carbon Monoxide Prodrugs for Acute Kidney Injury
$707,586Binghe Wang · Georgia State University · R01 · FY2023 · DK
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
$707,581Laura M Bohn · Scripps Florida · R01 · FY2012 · DA
CVD in American Indians Biomarker lab and Arizona Field Center
$707,555Barbara V Howard · Medstar Health Research Institute · R01 · FY2015 · HL
Improving Kidney Function Assessment in Health and Disease
$707,484Lesley Ann Inker · Tufts Medical Center · R01 · FY2022 · DK
CAREER: Machine Learning Approaches for Genome-wide Biological Network Inference
$707,335Xue-Wen Chen · University Of Kansas Center For Research Inc · · FY2007 · CSE